Beneficial effects of Rifaximin in post‐infectious irritable bowel syndrome mouse model beyond gut microbiota

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|33|2|443-452

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.33, Iss.2, 2018-02, pp. : 443-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systematic review with meta‐analysis: post‐infectious irritable bowel syndrome after travellers' diarrhoea

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 11, 2015-06 ,pp. : 1029-1037

John Wiley & Sons Inc

Access to resources Recommend Favorite

Altered faecal and mucosal microbial composition in post‐infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 4, 2015-02 ,pp. : 342-351

John Wiley & Sons Inc

Access to resources Recommend Favorite

Postinfectious irritable bowel syndrome after travelers' diarrhea – a cohort study

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 8, 2015-08 ,pp. : 1147-1155

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gut Microbiota Perturbations in Reactive Arthritis and Postinfectious Spondyloarthritis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 70, Iss. 2, 2018-02 ,pp. : 242-254

John Wiley & Sons Inc

Access to resources Recommend Favorite

Irritable bowel syndrome and somatization

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 5, 2015-05 ,pp. : 740-740

John Wiley & Sons Inc

Access to resources Recommend Favorite